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he problem of pathophysiological diagnosis in
psychiatry is unmet, with the possible exception of
Alzheimer’s disease. Diagnostic efforts including
International Classification of Diseases (ICD)
1 and
Diagnostic and Statistical Manual of Mental Disorders
(DSM),
2 are descriptive in nature and based on phenom-
enology.Virtually all of the phenomenological “markers”
can be arrived at through different gene–environment
interactions and via totally different pathways.The result
is a diagnosis based on phenomenological similarity and
a diagnostic category that is heterogeneous and unclear
regarding etiopathogenesis. The individuals so labeled
may resemble each other at a given moment in time,but
they are not classified on the basis of etiopathogenesis.
For the last 100 years,diagnosis in medicine has moved
away from phenomenology and toward etiopathogenesis.
It is that movement that has made for a truly scientific
medicine.Psychiatry must follow this path.The quest for
pathophysiological markers goes back to Emil Kraepelin
and continued for many years thereafter.With the advent
of psychodynamic thinking,the search for pathophysiol-
ogy diminished and was replaced by the search for inter-
nalized conflicts.Part of the reason for the failure of that
pathophysiological quest included limitations in the sci-
entific methods available to investigators.The develop-
ment of imaging technology has brought a dramatic
change in the power available to investigators.
Discriminates
In an article published in Science,
3 it was demonstrated
that data derived from quantitative electroencephalog-
raphy (EEG) were strongly correlated with DSM diag-
noses.The data were age-corrected and Z-transformed,
so as to make it possible to use appropriately powerful
statistical techniques (“neurometric analysis”) (Figure 1).
Discriminate equations could then be written,which,on
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T
Psychiatric diagnosis suffers from being based on phe-
nomenology and not on pathophysiology. Data are pre-
sented showing that psychiatric patients reveal consistent
quantitative electroencephalographic abnormalities, such
that they can be separated from normals and from each
other. Clustering these pathophysiological groupings
reveals an underlying variability, which permits useful sub-
typing. Data are presented relating subtyping to phar-
macological treatment.
Dialogues Clin Neurosci. 2002;4:329-335.the basis of EEG findings,could reliably separate psy-
chiatric patients from normals and classify patients along
the lines of the DSM nomenclature.The importance of
this finding was initially not fully recognized and brushed
aside as “merely correlational in nature.”Nevertheless,
there was a consistent and replicable demonstration of
abnormal brain activity as a function of diagnostic cate-
gory.A major limitation of the methodology was that the
signal is derived from the scalp,and the source of the sig-
nal was not localized three-dimensionally (Figure 2).
It became clear over time that some features of the
abnormal signal did not change with treatment or even
with clinical improvement.It can only be concluded that
the signal was a mixture of state and trait variables.
Nevertheless,it was clear that the patients who improved
clinically tended to move toward the normal space and
were less abnormal statistically than they had been prior
to successful treatment.
Cluster analysis
An interesting question then arose.While it is possible to
group patients according to their abnormal quantitative
EEG (qEEG) findings,does this mean that the groups
were homogeneous within themselves? The technique of
discriminate analysis cannot address this question. On
the other hand,the use of a cluster analysis technique will
assist in resolving this issue.
4
As can be seen in Figure 3, a perfect discriminate will
separate a group into variable sets,but it does not iden-
tify where they are located along the vector that sepa-
rates those variable sets.The cluster analysis will permit
an examination of which person identified as belonging
to a discriminate group most resembles his or her neigh-
bor.In other words,once we have separated a group via
the qEEG methodology into a diagnostic category,we
can ask which members of that category look most like
their neighbors and which do not.
A cluster analysis on obsessive-compulsive disorder
(OCD) revealed two distinct clusters (Figure 4).
5,6While
the patients could be identified by qEEG as OCD, they
clustered into two groupings.Being able to cluster individ-
uals has no meaning if the cluster is not related to some-
thing useful.The question was,do these clusters differ in
some clinically meaningful fashion? It turned out that
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Figure 1. Z transform of data derived from quantitative electroen-
cephalography (qEEG).
Z =
Subject value — Mean value of sample
Standard deviation of sample
Z ≈ Probability that subject value lies within "normal" range
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Figure 2. Power distribution in different diagnostic categories. 
Reproduced from reference 3: John ER, Prichep LS, Friedman J, Easton P.
Neurometrics: computer-assisted differential diagnosis of brain dysfunctions.
Science. 1988;293:162-169. Copyright © 1988, American Association for the
Advancement of Science.
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Figure 3. Subtyping psychiatric patients according to quantitative elec-
troencephalography (qEEG) profile.
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Figure 4. Cluster analysis of quantitative electroencephalography (qEEG)
data in obsessive-compulsive disorder (OCD).
Reproduced from reference 6: Prichep LS, Mas F, Hollander E, et al. Quantitative elec-
troencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Res.
1993;50:25-32. Copyright © 1993, Elsevier Science.
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Figure 5. Positron emission tomography (PET) in obsessive-compulsive dis-
order (OCD) responders (n=20) to selective serotonin reuptake
inhibitor treatment: comparisons between drug-free baseline and
retest. AC, anterior cingulate.
Reproduced from reference 7: Hansen ES, Prichep LS, Bolwig TG, John ER. Quantitative
electroencephalography in OCD patients treated with paroxetine. Clinical EEG. 2003.
In press. Copyright © 2003, EEG and Clinical Neuroscience Society.
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Figure 6. Group average topographic Z maps of quantitative electroen-
cephalography (qEEG) clusters within the attention-deficit dis-
order (ADD) population.
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-1.5members of cluster 1 were predominantly nonresponders
to selective serotonin reuptake inhibitors (SSRIs),while
members of cluster 2 were predominantly responders to
SSRIs.These rates of response and nonresponse of approx-
imately 80% are astonishing,especially given the fact that
the data were derived from the scalp and not from the
actual source of the abnormality.Three-dimensional source
localization via variable resolution electrical tomography
(VARETA) or magnetoencephalography would undoubt-
edly yield results that are more refined.
Figure 5 shows differences between positron emission
tomography (PET) images in OCD responders to SSRI
treatment at baseline and after successful treatment with
SSRI.
7 The localization of the metabolic changes was
consistent with the EEG source localization of the abnor-
mal activity.
A similar clustering algorithm was utilized for patients suf-
fering from attention-deficit disorder (ADD).The cohort
of ADD cases was divided into two clusters:76% of clus-
ter 1 responded to methylphenidate,whereas 62% of clus-
ter 2 responded better to dextroamphetamine (Table I).In
other words,despite the total similarity of these cases clin-
ically, the differential response to methylphenidate and
dextroamphetamine was determined to a large extent by
the distinctive pathophysiology revealed by cluster mem-
bership.Again,this cluster membership was determined
by the scalp signal and not based on three-dimensional
source localization (Figure 6).
VARETA images were computed at the qEEG frequen-
cies where the most significant changes occurred.Figure 7
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Figure 7. Quantitative electroencephalography (qEEG) variable resolution electrical tomography (VARETA) images at 6.63 Hz of an attention-deficit dis-
order (ADD) dextroamphetamine responder before and after medication.
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Table I. Relationship between quantitative electroencephalography (qEEG)
cluster membership and response to treatment in children with
attention-deficient disorder.
Responder Cluster 1 Cluster 2
n% n %
Methylphenidate 47 76 19 38
Dextroamphetamine 15 24 31 62shows VARETA images taken at 6.63 Hz on dextroam-
phetamine responders before and after medication.One
can see the obvious normalization with medication.
Figure 8 shows VARETA images at 5.85 Hz of dex-
troamphetamine nonresponders before and after med-
ication.An examination of this figure shows worsening
with medication.It should also be noted that the respon-
ders and nonresponders differed according to the
VARETA frequency.
The final grouping that will be reported in this paper con-
sists of a group of patients with schizophrenia,which were
subtyped into five clusters (Figure 9).Only members of
cluster 1 showed a greater than 25% reduction in Brief
Psychiatric Rating Scale (BPRS) with the use of haloperi-
dol.Members of cluster 3 responded best to risperidone.
What is apparent is that there were differential responses
to medication as a function of cluster membership.
These three clinical examples demonstrate the variability in
the pathophysiology within a so-called diagnostic category.
Conclusion
Figure 10 represents an uninformed cluster analysis of a
mixed population containing both normal and abnormal
individuals.They were clustered without diagnosis and
then later grouped by categories ranging from normal
through the various diagnostic labels. As is obvious,
whether normal or any other clinical category,there was
variability of cluster membership. Some members of a
particular diagnostic category were in a particular cluster,
while others of the same diagnostic category were in other
clusters.What is particularly striking is that while many
normals are in cluster 10,patients with a variety of psy-
chiatric disorders can also be found in cluster 10. This
raises the question as to whether these are normal people
only in the sense that they have not yet become ill,but in
fact have the trait variables that might be manifested in a
variety of different diagnostic categories.Belonging to a
particular cluster does not identify whether or not an indi-
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Figure 8. Quantitative electroencephalography (qEEG) VARETA images at 5.85 Hz of an attention-deficit disorder (ADD) dextroamphetamine nonre-
sponder before and after medication.
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Figure 9. Schizophrenia clusters (power).
Z
+1
-1
Z absolute power Z relative power
Total Beta
Cluster 1
(n=22)
Cluster 5
(n=14)
Cluster 4
(n=15)
Cluster 3
(n=23)
Cluster 2
(n=20)
Alpha Theta Delta Beta Alpha Theta Delta
Figure 10. Distribution (%) across the 12 clusters within the normal (NL) and each Diagnostic and Statistical Manual of Mental Disorders (DSM)
2 cate-
gory. SzN, nonmedicated schizophrenia patients; SzMed, medicated schizophrenia patients; SzFB, first-break schizophrenia patients.
Normal
SzN
SzMed
SzFB
Obsessive-compulsive disorder
Unipolar depression
Bipolar depression
Dementia
Mild cognitive impairment
Clustervidual will manifest clinical illness.Ultimately,the task is
to use three-dimensional source localization and more
refined analysis of the pathophysiology to separate trait
from state and thereby identify individuals who are at
future risk from those who are not.Finally,developing a
better understanding of pathophysiology will lead to
more specific and more effective treatment of the sub-
types of various psychiatric syndromes. ❏
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Subclasificación de los trastornos 
psiquiátricos: implicancias para el 
desarrollo de fármacos
Una de las dificultades que encuentra el diagnóstico
en psiquiatría es la de estar basado en la fenomeno-
logía y no en la fisiopatología. Los datos que se pre-
sentan en este artículo demuestran que los pacientes
psiquiátricos presentan anomalías electroencefalo-
gráficas cuantitativamente constantes, las cuales per-
miten separar a los sujetos normales de los pacientes
psiquíatricos y diferenciarlos entre ellos. El reunir
estas agrupaciones fisiopatológicas refleja una varia-
bilidad subyacente, lo que permite una útil subclasi-
ficación. Los datos que se presentan relacionan la
subclasificación con el tratamiento farmacológico.
Sous-types de troubles psychiatriques :
conséquences pour le développement des
médicaments
Le diagnostic psychiatrique souffre d’être basé sur la
phénoménologie et non sur la physiopathologie. Les
données montrent que les patients atteints de patho-
logie psychiatrique sont porteurs d’anomalies élec-
troencéphalographiques quantitatives constantes,
permettant de les séparer des sujets normaux et de
les différencier entre eux. Le regroupement de ces
ensembles physiopathologiques fait apparaître une
variabilité sous-jacente qui permet une classification
utile en sous-types. Les résultats montrent un lien
entre les sous-types et le traitement pharmacolo-
gique.